Literature DB >> 9893426

[A study of sialylated carbohydrate antigen in patients with benign bronchopulmonary disease].

T Yokoyama1, Y Ikedou, F Kido, S Tanoue, K Tashiro, H Ninomiya, T Rikimaru, A Kajiki, M Takamoto, T Ishibashi, K Oizumi.   

Abstract

We studied the levels of carbohydrate antigen (CA 19-9, SLX, CA 50, Span-1, and Dupan-2) in serum, bronchoalveolar lavage fluid, and tissue from patients with benign bronchopulmonary disease. Patients had bronchiectasis, healed pulmonary tuberculosis, pulmonary fibrosis, or other diseases. Bronchoalveolar lavage fluid levels and immunohistochemical findings for lung tissue samples, in the absence of digestive and other diseases, suggested that elevated serum sialylated Lewis(A) (CA 19-9, CA 50, and Span-1) and Lewis(X) (SLX) antigen in patients with benign broncho-pulmonary disease are due to marked production of sialylated carbohydrate antigen in respiratory bronchioles. Common features of patients with benign bronchopulmonary disease include elevated serum carbohydrate antigen levels and bronchiectasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9893426

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  3 in total

1.  Anomalous systemic arterial supply to the basal lung segments with high serum carbohydrate antigen 19-9 levels-a case report.

Authors:  Toshinari Ema; Hiroshi Neyatani; Saki Yamamoto; Shuhei Iizuka; Kazuyo Yasuda; Kazuhito Funai; Norihiko Shiiya
Journal:  AME Case Rep       Date:  2021-01-25

2.  Extremely increased serum carbohydrate antigen 19-9 levels caused by new or resistant infections to previous antibiotics in chronic lung diseases.

Authors:  Ji Young Shin; Su Jin Yoo; Bo Mi Park; Sung Su Jung; Ju Ock Kim; Jeong Eun Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-09-30

3.  A case of a jejunal gastrointestinal stromal tumor with significantly elevated CA19-9 levels.

Authors:  Koichi Mohri; Kazuhiro Hiramatsu; Yoshihisa Shibata; Taro Aoba; Masahiro Fujii; Atsuki Arimoto; Akira Ito; Takehito Kato
Journal:  Int J Surg Case Rep       Date:  2020-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.